Please login to the form below

Not currently logged in
Email:
Password:

Dan Zabrowski takes over as head of Roche Applied Science

Former global head of partnering succeeds Paul Brown

Dan Zabrowski - RocheRoche's Dan Zabrowski has assumed his new role as head of Roche Applied Science within the company's diagnostics division.

Zabrowski was previously global head of partnering at Roche and also sat on both the Roche corporate executive committee and the board of Roche's Japan-based subsidiary Chugai.

He will succeed Paul Brown, who has been in charge at Roche Applied Science since September 2011, and will relocate from Basel, Switzerland, to Penzberg, Germany. Once there Brown will remain head of Roche Molecular Diagnostics.

Zabrowski joined Syntex in 1993, before Roche acquired the company in 1994.

He has been with Roche ever since, holding a number of management positions in regulatory affairs and pharma development. He also holds a PhD in organic chemistry from the University of Indiana.

Roche CEO Severin Schwan said: “As head of applied science, Dan will be key for driving this strategically important business with our customers in academia, biotech and pharmaceutical industries.”

As previously announced, general manager of Roche Pharma in France Sophie Kornowski-Bonnet will take over Zabrowski's old role as head of partnering and relocate to the company's Basel-based headquarters.

2nd February 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics